These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3420026)

  • 1. Disseminated visceral leishmaniasis (kala azar) in acquired immunodeficiency syndrome (AIDS).
    Falk S; Helm EB; Hübner K; Stutte HJ
    Pathol Res Pract; 1988 Jun; 183(3):253-5. PubMed ID: 3420026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis (kala azar) in a patient with AIDS.
    Smith D; Gazzard B; Lindley RP; Darwish A; Reed C; Bryceson AD; Evans DA
    AIDS; 1989 Jan; 3(1):41-3. PubMed ID: 2496712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review].
    Joggi J; Chave JP; Bruni D; Schmidt PM
    Schweiz Med Wochenschr; 1990 Mar; 120(12):414-6. PubMed ID: 2181645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.
    Montalban C; Martinez-Fernandez R; Calleja JL; Garcia-Diaz JD; Rubio R; Dronda F; Moreno S; Yebra M; Barros C; Cobo J
    Rev Infect Dis; 1989; 11(4):655-60. PubMed ID: 2672242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 cases of visceral leishmaniasis, one in a HIV-positive man].
    Balslev U; Jonsbo F; Junge J; Bentsen KD
    Ugeskr Laeger; 1991 May; 153(22):1591-2. PubMed ID: 2058021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Visceral leishmaniasis associated with HIV infection].
    Rivero A; Santos J; Márquez M; Gavilán JC; Carralero C
    Enferm Infecc Microbiol Clin; 1989 Jan; 7(1):59-60. PubMed ID: 2490650
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].
    Botella Estrada R; Sanmartín Jiménez O; Febrer Bosch MI; Aliaga Boniche A; Salavert Lleti M; Roig Rico P; Nieto García A; Navarro Ibañez V
    Med Cutan Ibero Lat Am; 1990; 18(2):119-23. PubMed ID: 2214938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kala-azar comes to New York.
    Parkas V; Godwin J; Murray HW
    Arch Intern Med; 1997 Apr; 157(8):921-3. PubMed ID: 9129553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani.
    Albrecht H; Sobottka I; Emminger C; Jablonowski H; Just G; Stoehr A; Kubin T; Salzberger B; Lutz T; van Lunzen J
    Arch Pathol Lab Med; 1996 Feb; 120(2):189-98. PubMed ID: 8712898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leishmaniasis and HIV infection].
    Oliván A; Reparaz J; Uriz J; Solá J
    Enferm Infecc Microbiol Clin; 1989 Jan; 7(1):60. PubMed ID: 2490651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Visceral leishmaniasis in patients infected with HIV in the Barcelona area].
    Galofré J; Miró JM; Mallolas J; García-Ruz F; Grau JM
    Rev Clin Esp; 1990 Jun; 187(2):98-9. PubMed ID: 2244070
    [No Abstract]   [Full Text] [Related]  

  • 12. [Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients].
    Lüthy RM; Kistler HJ
    Schweiz Med Wochenschr; 1989 Sep; 119(38):1309-13. PubMed ID: 2587969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)].
    Just G; Simader R; Helm EB; Stille W; Falk S; Stutte HJ; Hübner K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1920-2. PubMed ID: 2848675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visceral leishmaniasis: a new opportunistic infection in carriers of the human immunodeficiency virus].
    Montalbán C; Calleja JL
    Med Clin (Barc); 1990 Feb; 94(5):176-9. PubMed ID: 2325477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Visceral leishmaniasis in immunosuppressed patients].
    Rousaud Barón F
    Rev Clin Esp; 1992 May; 190(9):481. PubMed ID: 1626102
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.
    Das VN; Pandey K; Verma N; Bimal S; Lal CS; Singh D; Das P
    Natl Med J India; 2010; 23(2):88-9. PubMed ID: 20925205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral leishmaniasis and immunosuppression].
    Lortholary O; Christiaens D; Mechali D; Babinet P
    Ann Med Interne (Paris); 1991; 142(3):215-7. PubMed ID: 1854134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination].
    Belda Mira A; Díaz Sánchez F; Martínez García B; Gonzalvo Bellver E; Antón Crespo V; Redón Mas J
    An Med Interna; 1994 Aug; 11(8):398-400. PubMed ID: 7772689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
    Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
    AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
    Ermak TN; Kravchenko AV; Gruzdev BM; Filippov PG
    Ter Arkh; 1997; 69(11):48-50. PubMed ID: 9483748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.